Cargando…
P1100: PET INTERIM RESULTS COULD PROMPTLY SELECT FOLLICULAR LYMPHOMA PATIENTS IN NEED OF MAINTENANCE THERAPY. POTENTIAL ADDITIONAL VALUE OF CFDNA.
Autores principales: | Poza, Maria, López-Pereira, Patricia, Figaredo García-Mina, Gloria, Zamanillo Herreros, Irene, Íñiguez García, Rodrigo, Gómez-Rojas, Sandra, Pérez Segura, Gloria, Ayala, Rosa, Baumann, Tycho, Rodriguez Izquierdo, Antonia, Barrio García, Santiago, Martín-Muñoz, Alejandro, Sarandeses, Pilar, Revilla, Enrique, Dorado, Sara, Rodriguez, Margarita, Martínez-López, Joaquín, Ubieto, Ana Isabel Jimenez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430898/ http://dx.doi.org/10.1097/01.HS9.0000971296.89233.96 |
Ejemplares similares
-
P1132: PET INTERIM RESULTS PREDICT PROGRESSION-FREE-SURVIVAL IN FOLLICULAR LYMPHOMA PATIENTS WITH ADVANCED STAGE
por: Poza, M., et al.
Publicado: (2022) -
PB2091: INFLUENCE OF HISTOLOGICAL GRADE IN CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME OF FOLICULAR LYMPHOMA
por: Zamanillo, I., et al.
Publicado: (2022) -
Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
por: Jiménez-Ubieto, Ana, et al.
Publicado: (2023) -
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
por: Jiménez-Ubieto, Ana, et al.
Publicado: (2023) -
Ibrutinib effect in acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia
por: Poza, María, et al.
Publicado: (2021)